← Back to BOLT

Bolt Biotherapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 12/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 11/08/2026Mar 2025Filed 12/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 12/05/2025
$0$0$2.2$1.8$1.2$1.1$1.3$5.3
−$7.7−$7.2−$7.1−$8.6−$11−$15−$21−$11
−$4.57−$4.31−$3.72−$4.46−$5.76−$7.93−$11.12−$0.28
1.71.71.91.938

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.